Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis

scientific article

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1001/2012.JAMA.11374
P698PubMed publication ID22968891

P2093author name stringEftychia Bika
Evangelia E Ntzani
Evangelos C Rizos
Michael S Kostapanos
Moses S Elisaf
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectfatty acidQ61476
cardiovascular diseaseQ389735
systematic reviewQ1504425
meta-analysisQ815382
P304page(s)1024-1033
P577publication date2012-09-01
P1433published inThe Journal of the American Medical AssociationQ1470970
P1476titleAssociation between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis
P478volume308

Reverse relations

cites work (P2860)
Q39658997(De-) oiling inflammasomes
Q267475592015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Q569915252016 European Guidelines on cardiovascular disease prevention in clinical practice
Q894902512016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repre
Q340468812016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres
Q3575020621 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo
Q904394185 Conservative treatment for PAD - Risk factor management
Q28972330A Comparative Overview of Prescription Omega-3 Fatty Acid Products
Q27860879A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Q42379898A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents
Q35675778A flood of health functional foods: what is to be recommended?
Q40064587A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion
Q88564337A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia
Q37268776A point mutation in the human Slo1 channel that impairs its sensitivity to omega-3 docosahexaenoic acid.
Q38167290Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators
Q34767372Advancing beyond the "heart-healthy diet" for peripheral arterial disease
Q37289809Analysis of the omega-3 fatty acid content of South African fish oil supplements: a follow-up study
Q37170684Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
Q52879007Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention.
Q37308578Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes
Q36081622Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
Q39630777Association of Specific Dietary Fats With Total and Cause-Specific Mortality
Q42629577Association of a Low Serum Eicosapentaenoic Acid/Arachidonic Acid Ratio with the Risk of Acute Venous Thromboembolism
Q51075501Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.
Q37216716Association of dietary omega-3 fatty acids with prevalence of metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study
Q40749644Association of fish consumption and dietary intake of marine n-3 PUFA with myocardial infarction in a prospective Danish cohort study
Q64097026Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance
Q48517326Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Q90050475Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study
Q37590642Associations of long-chain ω-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort
Q40845482Associations of serum n-3 and n-6 PUFA and hair mercury with the risk of incident stroke in men: the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD).
Q35525108Atherosclerosis in systemic lupus erythematosus
Q50083483Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals.
Q28084681Beneficial effects of omega-3 polyunsaturated Fatty acids in gestational diabetes: consequences in macrosomia and adulthood obesity
Q26740486Benefit-Risk Assessment of Fish Oil in Preventing Cardiovascular Disease
Q38100747Beyond statins: lipid management to reduce cardiovascular risk
Q39004398Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention
Q38974093Biological and pathophysiological roles of end-products of DHA oxidation.
Q38171245Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans
Q90193519Bioprospecting for Antithrombotic Polar Lipids from Salmon, Herring, and Boarfish By-Products
Q35642914Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver
Q89570815Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies
Q53098674Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats.
Q40196363Cardioprotective effects of ω -3 PUFAs in chronic kidney disease
Q39420208Cardiovascular disease prevention strategies for type 2 diabetes mellitus
Q44579003Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1.
Q35870114Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation
Q28109335Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011
Q37055557Changes in fish consumption in midlife and the risk of coronary heart disease in men and women
Q36482335Characterization and cytotoxicity studies of the rare 21:4 n-7 acid and other polyunsaturated fatty acids from the marine opisthobranch Scaphander lignarius, isolated using bioassay guided fractionation.
Q35650897Circulating B-vitamins and smoking habits are associated with serum polyunsaturated Fatty acids in patients with suspected coronary heart disease: a cross-sectional study
Q89958688Circulating Fatty Acids and Risk of Coronary Heart Disease and Stroke: Individual Participant Data Meta-Analysis in Up to 16 126 Participants
Q30415330Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis
Q64093116Clinical Advances in Immunonutrition and Atherosclerosis: A Review
Q45706448Clinical trials must cope better with multiplicity
Q34411678Cod liver oil supplement consumption and health: cross-sectional results from the EPIC-Norfolk cohort study
Q43121360Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639.
Q64993097Comparison of Cardiovascular Outcomes Between Statin Monotherapy and Fish Oil and Statin Combination Therapy in a Veteran Population.
Q46890454Comparison of serum fatty acid concentrations in cats with hypertrophic cardiomyopathy and healthy controls
Q100415934Competitive reduction of poultry-borne enteric bacterial pathogens in chicken gut with bioactive Lactobacillus casei
Q36846142Complementary and alternative medicine and cardiovascular disease: an evidence-based review
Q92733573Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?
Q60458824Could an El Niño event put dietary supplies of n-3 long-chain polyunsaturated fatty acids (EPA and DHA) in jeopardy
Q38186099Critical review of non-statin treatments for dyslipoproteinemia.
Q38546242Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
Q36064353Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets
Q61812139DNA methylation GrimAge strongly predicts lifespan and healthspan
Q92678637DNA methylation-based estimator of telomere length
Q26823558Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke
Q89365604Dietary Docosahexaenoic Acid Reduces Oscillatory Wall Shear Stress, Atherosclerosis, and Hypertension, Most Likely Mediated via an IL-1-Mediated Mechanism
Q38904288Dietary Self-management in Heart Failure: High Tech or High Touch?
Q36746574Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review
Q92091772Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes
Q35011156Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study
Q38726519Dietary management of heart failure: room for improvement?
Q28235974Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway
Q35036431Dietary omega-3 fatty acids promote arrhythmogenic remodeling of cellular Ca2+ handling in a postinfarction model of sudden cardiac death
Q26865717Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis
Q42721304Dietary supplementation with Lovaza and krill oil shortens the life span of long-lived F1 mice
Q87771640Dietary supplementation with fish oil alters the expression levels of proteins governing mitochondrial dynamics and prevents high-fat diet-induced endothelial dysfunction
Q35233185Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials
Q36877629Dietary α-Linolenic Acid, Marine ω-3 Fatty Acids, and Mortality in a Population With High Fish Consumption: Findings From the PREvención con DIeta MEDiterránea (PREDIMED) Study
Q36432334Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids
Q34102651Do omega-3 polyunsaturated Fatty acids prevent cardiovascular disease? A review of the randomized clinical trials
Q56030877Docosahexaenoic acid supports feto-placental growth and protects cardiovascular and cognitive function: A mini review
Q38156593Docosahexaenoic acid, protectin synthesis: relevance against atherothrombogenesis
Q33901461Does APOE genotype modify the relations between serum lipid and erythrocyte omega-3 fatty acid levels?
Q39255894Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
Q90641158Dose-response effects of omega-3 on platelet aggregation: an observational study
Q34099690Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis
Q50180407Dyslipidaemia in the elderly: to treat or not to treat?
Q39045120Dyslipidemia in patients with chronic kidney disease
Q37496646ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement
Q91593307ESVM Guideline on peripheral arterial disease
Q49353034Effect of Dietary Counseling on a Comprehensive Metabolic Profile from Childhood to Adulthood.
Q53251167Effect of Sardina pilchardus oil on alloxan-induced diabetic rats.
Q36721935Effect of Vitamin D3 on Monocyte Chemoattractant Protein 1 Production in Monocytes and Macrophages
Q60432116Effect of diet on vascular health
Q47896524Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles.
Q35838579Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials
Q37106424Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).
Q42550065Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: a randomized, controlled trial
Q36232162Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis
Q55346464Effect of supplementation with flaxseed oil and different doses of fish oil for 2 weeks on plasma phosphatidylcholine fatty acids in young women
Q33893037Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review
Q57174292Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
Q37589150Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia.
Q59812686Effects of fatty and lean fish intake on stroke risk: a meta-analysis of prospective cohort studies
Q98613050Effects of fish oil during hemodialysis on nutritional status and quality of life: a randomized double-blinded trial
Q49166092Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomised controlled trial.
Q35131500Effects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet
Q37704000Effects of omega-3 polyunsaturated Fatty acids on heart function and oxidative stress biomarkers in pediatric patients with dilated cardiomyopathy
Q34228522Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
Q33820362Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
Q34250605Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial
Q51334679Emerging approaches for the treatment of hypertriglyceridemia.
Q38263909Emerging drugs for hyperlipidaemia: an update
Q38082485Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis
Q28080910Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives
Q36085738Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice
Q92757574Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption
Q39441530Enriching Diet with n-3 PUFAs to Help Prevent Cardiovascular Diseases in Healthy Adults: Results from Clinical Trials
Q38289067Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic β-Cell Function.
Q33604527Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementation
Q55496344Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study.
Q34880292Evolving targets for lipid-modifying therapy
Q35748105Experimental and computational studies of fatty acid distribution networks.
Q36660183Fat chance for longevity
Q46691449Fatty Acid and Lipid Profiles with Emphasis on n-3 Fatty Acids and Phospholipids from Ciona intestinalis
Q46488015Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète
Q21246041Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
Q39416756Fish consumption and all-cause mortality in a cohort of Swedish men and women
Q54963379Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study.
Q37276244Fish intake and risks of total and cause-specific mortality in 2 population-based cohort studies of 134,296 men and women
Q46415716Fish intake or omega-3 fatty acids: greater than the sum of all parts?
Q46118317Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study
Q34988645Fish oil and atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials
Q36960923Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial
Q34796255Fish oil and the pan-PPAR agonist tetradecylthioacetic acid affect the amino acid and carnitine metabolism in rats
Q34752039Fish oil for prevention of sudden death in hemodialysis patients?
Q38081054Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins
Q36754545Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy
Q40396866Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults
Q34678652Fish oil supplementation induces expression of genes related to cell cycle, endoplasmic reticulum stress and apoptosis in peripheral blood mononuclear cells: a transcriptomic approach
Q60950118Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?
Q36019764Fish, omega-3 long-chain fatty acids, and all-cause mortality in a low-income US population: Results from the Southern Community Cohort Study
Q43126586Fishing for answers: is oxidation of fish oil supplements a problem?
Q28073362Fit with good fat? The role of n-3 polyunsaturated fatty acids on exercise performance
Q26782788Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation
Q42535981Food science and food ingredients: the need for reliable scientific approaches and correct communication, Florence, 24 March 2015.
Q38129930Food security and cardioprotection: the polar lipid link
Q33467115Formation of reactive aldehydes (MDA, HHE, HNE) during the digestion of cod liver oil: comparison of human and porcine in vitro digestion models
Q52149532From alga to omega; have we reached peak (fish) oil?
Q64113836GC-MS-Based Metabolomics to Reveal the Protective Effect of Gross Saponins of Fruit against Ischemic Stroke in Rat
Q38809442Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes
Q34212894Genetic predisposition scores for dyslipidaemia influence plasma lipid concentrations at baseline, but not the changes after controlled intake of n-3 polyunsaturated fatty acids.
Q34036583Genetic variation in FADS1 has little effect on the association between dietary PUFA intake and cardiovascular disease.
Q46019628Genome-wide association meta-analysis of fish and EPA+DHA consumption in 17 US and European cohorts.
Q37278159Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men
Q55286155Green leafy vegetables in diets with a 25:1 omega-6/omega-3 fatty acid ratio modify the erythrocyte fatty acid profile of spontaneously hypertensive rats.
Q85744452Greene et al. respond
Q89897478Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women
Q57056329Health Information Discrepancies Between Internet Media and Scientific Papers Reporting on Omega-3 Supplement Research: Comparative Analysis
Q22241921Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association
Q30238784Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association
Q29547691Heart disease and stroke statistics--2014 update: a report from the American Heart Association
Q36080332Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
Q52778826High consumption of farmed salmon does not disrupt the steady state of persistent organic pollutants (POP) in human plasma and adipose tissue.
Q37114699High potency fish oil supplement improves omega-3 fatty acid status in healthy adults: an open-label study using a web-based, virtual platform.
Q34179555High-fat meals rich in EPA plus DHA compared with DHA only have differential effects on postprandial lipemia and plasma 8-isoprostane F2α concentrations relative to a control high-oleic acid meal: a randomized controlled trial
Q36087812Higher Plasma Phospholipid n-3 PUFAs, but Lower n-6 PUFAs, Are Associated with Lower Pulse Wave Velocity among Older Adults
Q38856659How reliable are randomised controlled trials for studying the relationship between diet and disease? A narrative review
Q49592460Hypercholesterolaemia - practical information for non-specialists.
Q34687470Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
Q55005204Identification and Quantification of Fatty Acids in T. viridissima, C. biguttulus, and C. brunneus by GC-MS.
Q92005193Identification of the 12q24 locus associated with fish intake frequency by genome-wide meta-analysis in Japanese populations
Q38099615Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation
Q51364877Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study.
Q57296672Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease
Q37177415Impact of docosahexaenoic acid on gene expression during osteoclastogenesis in vitro--a comprehensive analysis
Q47177161Impact of heterogeneity and effect size on the estimation of the optimal information size: analysis of recently published meta-analyses
Q36419548Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans
Q34142519Importance of fatty acid compositions in patients with peripheral arterial disease
Q33822096Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice
Q35034713Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids
Q34468355Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
Q26769891Inflammatory bowel disease: can omega-3 fatty acids really help?
Q47195608Influence of pharmacological education on perceptions, attitudes and use of dietary supplements by medical students
Q99573757Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases
Q37612576Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality.
Q39420468Interaction between dietary marine-derived n-3 fatty acids intake and J-point elevation on the risk of cardiac death: a 24-year follow-up of Japanese men.
Q47792010Involvement of dietary Fatty acids in multiple biological and psychological functions, in morbidly obese subjects
Q64075478Is Grassfed Meat and Dairy Better for Human and Environmental Health?
Q35179684Is omega-3 fatty acids enriched nutrition support safe for critical ill patients? A systematic review and meta-analysis
Q64281669Knowledge, attitude, and practices regarding dietary supplements in Saudi Arabia
Q36370184Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study
Q33689091Lifespan effects of simple and complex nutraceutical combinations fed isocalorically to mice
Q36844453Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children
Q40196417Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.
Q59132881Linoleic Acids Overproducing Limits Growth, Survival, and Virulence of Typhimurium and Enterohaemorrhagic
Q38222135Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications.
Q35536385Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk
Q36200061Long chain n-3 polyunsaturated fatty acids and vascular function in patients with chronic kidney disease and healthy subjects: a cross-sectional and comparative study
Q38151841Long-chain omega-3 fatty acids: time to establish a dietary reference intake
Q58496691Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis
Q35239530Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative
Q34365060Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].
Q37620599Longitudinal and secular trends in dietary supplement use: Nurses' Health Study and Health Professionals Follow-Up Study, 1986-2006.
Q42650102Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
Q41636643Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm
Q36963353Low-event-rate meta-analyses of clinical trials: implementing good practices
Q43949640Macronutrients intake and risk of Parkinson's disease: A meta-analysis
Q50099270Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Q87857921Management of Measurable Variable Cardiovascular Disease' Risk Factors
Q89834651Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020
Q55044908Marine Omega-3 Fatty Acids, Complications of Pregnancy and Maternal Risk Factors for Offspring Cardio-Metabolic Disease.
Q90367323Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants
Q42918063Marine n-3 Fatty Acids and Gene Expression in Peripheral Blood Mononuclear Cells
Q92980824Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Q27690878Marine omega-3 phospholipids: metabolism and biological activities
Q92703441Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance
Q58794187Maternal omega-3 polyunsaturated fatty acid supplementation on offspring hip joint conformation
Q38083007Medical management of stable coronary atherosclerosis.
Q36482611Mercury, selenium and fish oils in marine food webs and implications for human health
Q33601360Meta-analysis of oxidative stress in schizophrenia
Q35152158Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts
Q37720139Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: the TRIUMPH Study.
Q55073652N-3 PUFA increase bioavailability and function of endothelial progenitor cells.
Q43628051N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia
Q37010680N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis
Q51758644Natural approaches in metabolic syndrome management.
Q89260061Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases
Q48749026No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: the Alpha Omega Trial.
Q36068816Nutraceutical therapies for atherosclerosis.
Q26747475Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk Reduction
Q59810585Nutrient Supplement Use among the Chinese Population: A Cross-Sectional Study of the 2010⁻2012 China Nutrition and Health Surveillance
Q28078517Nutrient reference value: non-communicable disease endpoints--a conference report
Q47552947Nutritional Supplement and Functional Food Use Among Medical Students in India
Q38994790Nutritional Supplements for the Treatment of Hypertension: A Practical Guide for Clinicians
Q37235410Nutritional recommendations for cardiovascular disease prevention
Q42447279Omega 3 chronic supplementation attenuates myocardial ischaemia-reperfusion injury through reinforcement of antioxidant defense system in rats.
Q40074654Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts
Q28084892Omega-3 Fatty Acids and Skeletal Muscle Health
Q37626547Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers
Q30235305Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
Q26798054Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall
Q26798057Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence
Q36287625Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis
Q38930015Omega-3 fatty acids (ω-3 fatty acids) in epilepsy: animal models and human clinical trials
Q85632451Omega-3 fatty acids and cardioprotection-IIb or not IIb?
Q38233967Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors
Q38160641Omega-3 fatty acids and cardiovascular disease: new developments and applications
Q38736964Omega-3 fatty acids as an adjunct for periodontal therapy-a review
Q28080498Omega-3 fatty acids for breast cancer prevention and survivorship
Q89958068Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q90307768Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q55919856Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q38176274Omega-3 fatty acids: a growing ocean of choices
Q38152943Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management
Q37571905Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis
Q30409882Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus
Q38083612Omega-3 in antiarrhythmic therapy : pros position
Q37617749Omega-3 index and cardiovascular health
Q58739768Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
Q26747026Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease
Q41996741Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introduction
Q38260532Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia
Q38680756Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future
Q37004879Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease
Q92633824Omega-3 supplement use, fish intake, and risk of non-fatal coronary artery disease and ischemic stroke in the Million Veteran Program
Q26864908Omega-3 supplements and cardiovascular diseases
Q27686781Omega-3s and cardiovascular health.
Q36561806Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis
Q37419411Overview of omega-3 Fatty Acid therapies
Q21284850Oxidation of marine omega-3 supplements and human health
Q49377009PM2.5 inhalation induces intracranial atherosclerosis which may be ameliorated by omega 3 fatty acids.
Q37206674PURLs: should you still recommend omega-3 supplements?
Q52369219Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.
Q38191066Pharmacotherapy to reduce arrhythmic mortality
Q47840702Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties.
Q59390185Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients
Q50077478Plasma n-3 and n-6 Fatty Acids Are Differentially Related to Carotid Plaque and Its Progression: The Multi-Ethnic Study of Atherosclerosis.
Q24633239Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial
Q36974431Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study
Q57806953Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders-A Review
Q36926384Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: a cross-sectional study
Q58804123Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure
Q38460480Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies
Q39076677Prenatal Docosahexaenoic Acid Supplementation Does Not Affect Nonfasting Serum Lipid and Glucose Concentrations of Offspring at 4 Years of Age in a Follow-Up of a Randomized Controlled Clinical Trial in Mexico.
Q33845330Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study.
Q38856700Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women
Q26822760Prevention and management of type 2 diabetes: dietary components and nutritional strategies
Q90467118Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved
Q38644827Principles in the Evaluation of Systematic Reviews
Q38168873Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials.
Q26851781Public Health Perspectives on Aquaculture
Q35151307Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Q34536800Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?
Q36355384Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms
Q38899898Regulation of inflammation by lipid mediators in oral diseases
Q26996039Residual macrovascular risk in 2013: what have we learned?
Q45064553Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications
Q47633216Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids
Q24564203Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
Q90283300Role of Oleic Acid in the Gut-Liver Axis: From Diet to the Regulation of Its Synthesis via Stearoyl-CoA Desaturase 1 (SCD1)
Q38353525Role of fish oil in human health and possible mechanism to reduce the inflammation
Q38116485Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.
Q93120785Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular disease
Q26799530Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment
Q38379544Saturated Fats and Cardiovascular Disease: Interpretations Not as Simple as They Once Were
Q33856033Saturated Fatty Acids and Cardiovascular Disease: Replacements for Saturated Fat to Reduce Cardiovascular Risk.
Q47154740Scientific Opinion on health benefits of seafood (fish and shellfish) consumption in relation to health risks associated with exposure to methylmercury
Q33698614Selection in Europeans on Fatty Acid Desaturases Associated with Dietary Changes
Q36412184Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities
Q55499401Sex Differences in Omega-3 and -6 Fatty Acids and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO Study.
Q38903226Short Chain and Polyunsaturated Fatty Acids in Host Gut Health and Foodborne Bacterial Pathogen Inhibition.
Q36141602Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)
Q42629565Significance of Serum Polyunsaturated Fatty Acid Level Imbalance in Patients with Acute Venous Thromboembolism
Q41158349Significance of long chain polyunsaturated fatty acids in human health.
Q28304230Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer
Q38881156Statin combination therapy and cardiovascular risk reduction
Q38338721Strategic nutrition: a vision for the twenty-first century
Q55470328Structural Elucidation of Irish Organic Farmed Salmon (Salmo salar) Polar Lipids with Antithrombotic Activities.
Q89749602Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment
Q91654760Synergistic anti-atherosclerotic role of combined treatment of omega-3 and co-enzyme Q10 in hypercholesterolemia-induced obese rats
Q38904497Targeting ApoC-III to Reduce Coronary Disease Risk
Q33586632The 2015 Dutch food-based dietary guidelines
Q26781534The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
Q58571873The Effects of Omega-3 and Vitamin E Co-supplementation on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome
Q57475802The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Q92255416The Mediterranean Diet Slows Down the Progression of Aging and Helps to Prevent the Onset of Frailty: A Narrative Review
Q37142034The PBMC transcriptome profile after intake of oxidized versus high-quality fish oil: an explorative study in healthy subjects
Q53480627The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy.
Q48943429The Role of Omega-3 Fatty Acids in Diets.
Q55515152The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins.
Q90247594The Supportive Treatment of IgA Nephropathy and Idiopathic Nephrotic Syndrome: How Useful are Omega-3 Polyunsaturated Fatty Acids?
Q35848011The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study
Q35817077The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.
Q38419205The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs
Q47598211The cardiovascular benefits of indiscriminate supplementation of omega-3 fatty acids; meta-analysis and decision-making approach
Q35395358The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.
Q26822900The failure of cancer chemoprevention
Q38683354The future for long chain n-3 PUFA in the prevention of coronary heart disease: do we need to target non-fish-eaters?
Q38928300The impact of fatty acid desaturase genotype on fatty acid status and cardiovascular health in adults
Q26852020The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis
Q64912251The injured brain might need more fat!
Q87209329The percentage of DHA in erythrocytes can detect non-adherence to advice to increase EPA and DHA intakes
Q34359967The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Q36261660The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study
Q41675416The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: the Framingham Heart Study
Q36495874The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease.
Q38185266The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease
Q26830164The year in atherothrombosis
Q43123138Trans fatty acid isomers in mortality and incident coronary heart disease risk
Q37510091Treadmill exercise promotes neuroprotection against cerebral ischemia-reperfusion injury via downregulation of pro-inflammatory mediators
Q38553332Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy
Q47358362Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014.
Q41104057Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011.
Q36143171Update on the Vitamin D and OmegA-3 trial (VITAL).
Q34961885Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists.
Q30587127Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis
Q48257266Variability in the cardiometabolic effects of ω-3 long-chain PUFAs: background diet, timing, and genetics
Q47642249Very long-chain n-3 fatty acids and human health: fact, fiction and the future
Q26796303Vitamin E function and requirements in relation to PUFA
Q37557154Why fish oil fails: a comprehensive 21st century lipids-based physiologic analysis
Q88007987[On the overestimation of the benefit of prevention]
Q52838993[Severe hypertriglyceridemia : Diagnostics and new treatment principles].
Q50075478[Therapeutic options in hyperlipidemia].
Q92146832n-3 Fatty acids and risk for fatal coronary disease
Q51312635n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.
Q47396742n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises; A Contemporary Review.
Q38174039n-3 Polyunsaturated fatty acids modulate metabolism of insulin-sensitive tissues: implication for the prevention of type 2 diabetes
Q33819705n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
Q38119178n-3 fatty acids and cardiovascular disease: the story is not over yet.
Q36809876{Omega}-3 fatty acid supplement use in the 45 and Up Study Cohort
Q26782277ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary Relevance
Q39644797ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies
Q44487661ω-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle.
Q39041784ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.

Search more.